These findings indicate that dysregulations of HDAC2 and HDAC5 promote the development of hormone independency and tamoxifen resistance in ER+ breast cancer cells in part through expression regulations of survivin and miR-125a-5p. This evidence concerns the gene HDAC2 and breast cancer.